PPARGC1A and liver cancer: On the other hand, Ballah et al. showed that loss of PGC-1α in whole-body knockout mice prevented diethylnitrosamine (DEN)-induced liver cancer development and overexpression of the coactivator promotes tumor development in a xenograft model by increasing lipogenesis [196].